Chiu laboratory at UCSF

Our new paper on neutralizing immunity in Omicron and Delta breakthrough infections is out in @CellCellPress! This is another productive collaboration between @Chiulab_UCSF @TheOttLab @andinolab @doudna_lab @AbbottNews and the CA Dept of Public Health. cell.com/cell/fulltext/…

We recently worked with the @Chiulab_UCSF to develop a SNP-detecting #CRISPR system for #SARSCoV2 variant surveillance. Learn about our pipeline for developing Cas proteins for this & many other exciting applications in this @GenomeWeb article: genomeweb.com/molecular-diag… #COVID19

medrxiv.org/content/10.110… Our pre-print on the genomic investigation of severe pediatric hepatitis cases in the US; a great collaborative effort between our lab, the CDC, and several public health laboratories

⭐ NEW RESEARCH! Servellita et al. develop a #MachineLearning classifier for gene expression-based identification of early #LymeDisease | @cychiu98 @Chiulab_UCSF ow.ly/L1Ku50K3fpO

Our latest collaboration with @mammothbiosci - using LAMP and CRISPR for the rapid detection of SARS-CoV-2 variants journals.asm.org/doi/full/10.11…

@LoyConor @DeVlaminckLab @Chiulab_UCSF @VirusDocDeBiasi Overlap in pro-inflammatory genes and pathways between COVID-19 and MIS-C news-medical.net/news/20220623/… #Genes #Coronavirus #Disease #COVID #MISC #Nucleicacid #biomarkers @medrxivpreprint @Cornell @UCSF @ChildrensNatl @UCSFBenioffOAK @EmoryUniversity

Our #SARSCoV2 #COVID19 paper on limited cross-variant immunity in unvaccinated individuals vs Omicron is out in Nature. Please get vaccinated! @TheOttlab @doudna_lab @Chiulab_UCSF Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination nature.com/articles/s4158…

say hello to our newest Chiu lab scientist, Baby Geny!

Chiu Lab x SFDPH/Color Genomics @cychiu98 @veniceskaufman nature.com/articles/s4156…